How Professional Crypto Traders Use Multiple Exchanges to Arbitrage Execution, Not Just PriceJune 1, 2026
Stock Cisco (CSCO) Stock Reaches Record Peak as Wall Street Eyes More UpsideBy Trader EdgeApril 20, 2026
Stock BlackBerry (BB) Stock Jumps 15% on NVIDIA Edge AI Collaboration AnnouncementBy Trader EdgeApril 20, 2026
Stock PayPal (PYPL) Stock Tumbles as Mizuho Cuts Rating Amid X Money CompetitionBy Trader EdgeApril 20, 2026
Crypto Strategy (MSTR) Stock Dips Despite Massive $2.54B Bitcoin AcquisitionBy Trader EdgeApril 20, 2026
Stock Okta (OKTA) Stock Surges 4% Following Dual Analyst Upgrades on AI Security MomentumBy Trader EdgeApril 20, 2026
Stock Northrop Grumman (NOC) Q1 Earnings Preview: Will Margins Finally Recover?By Trader EdgeApril 20, 2026
Stock Marvell Technology (MRVL) Stock: Emerging AI Chip Leader Poised for GrowthBy Trader EdgeApril 20, 2026
Stock OpenAI Prepares to Challenge Google’s Dominance with Advanced Image AI ToolBy Trader EdgeApril 20, 2026
Stock Arista Networks (ANET) and IBM (IBM) Earn Evercore’s Tactical Outperform Status Pre-EarningsBy Trader EdgeApril 20, 2026
Stock Adobe (ADBE) Stock Gains Momentum Following AI Enterprise Platform DebutBy Trader EdgeApril 20, 2026
Stock Enveric Biosciences (ENVB) Stock Rockets 160% Following Presidential Psychedelics InitiativeBy Trader EdgeApril 20, 2026
Stock Clearmind Medicine (CMND) Stock Doubles on Positive Phase I/IIa Trial ResultsBy Trader EdgeApril 20, 2026
Stock Amazon (AMZN) Stock: How Anthropic’s $30B ARR Is Fueling AWS GrowthBy Trader EdgeApril 20, 2026
Stock COMPASS Pathways (CMPS) Stock Soars 25% as Trump Administration Backs Psychedelic MedicineBy Trader EdgeApril 20, 2026
Stock 5 Leading Cloud and AI Infrastructure Stocks Drawing Analyst Attention in 2026By Trader EdgeApril 20, 2026
Stock Rocket Lab (RKLB) Stock: Wall Street Sets $105 Target Amid Mynaric AcquisitionBy Trader EdgeApril 20, 2026
Stock Robinhood (HOOD) Stock Gets $115 Price Target After SEC Eliminates Day Trading RestrictionsBy Trader EdgeApril 20, 2026
Stock Definium Therapeutics (DFTX) Stock Soars to New Peak Following Trump’s Psychedelic Research InitiativeBy Trader EdgeApril 20, 2026
Stock Theriva Biologics (TOVX) Shares Soar 63% on Promising Pancreatic Cancer Trial ResultsBy Trader EdgeApril 20, 2026
Stock Salesforce (CRM) Stock Tumbles 30% in 2026 Amid AI Disruption ConcernsBy Trader EdgeApril 20, 2026
